Serial Number
90633201
Owner
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICESAttorney
Angela Y. DaiFiling Date
Apr 8, 2021
COVID-19 TEST US Trademark
Serial Number: 90633201 • Registration: 6909558
Trademark Classes
Owner Contact Info
8600 ROCKVILLE PIKE
BETHESDA, MD 20894
Entity Type: 14
Legal Representation
Trademark Details
Filing Date
April 8, 2021
Registration Date
November 29, 2022
Published for Opposition
September 13, 2022
Goods & Services
Downloadable electronic newsletters and flyers in the field of research for screening and diagnostic tests and/or devices for detection of viruses; downloadable electronic newsletters and flyers in the field of research for screening and diagnostic tests and/or devices for detection of SARS-CoV-2 and its variants that are attributed to COVID-19
Conducting research and clinical trials for others relating to medical devices and medical diagnostic tests used for detecting viruses; Conducting research and clinical trials for others relating to medical devices and medical diagnostic tests used for detecting SARS-CoV-2 and its variants; Evaluating and analyzing viruses in the nature of medical research in the field of virology; Medical and scientific research information in the field of virology; Providing temporary use of online non-downloadable software for participant enrollment in and documentation of clinical studies for screening and diagnostic tests and/or devices for viruses; Providing temporary use of online non-downloadable software for participant enrollment in and documentation of clinical studies for screening and diagnostic tests and/or devices for SARS-CoV-2 and its variants; Product safety testing, namely, testing the safety of medical diagnostic devices; Technical verification and validation of medical diagnostic tests; Safety testing of products used in connection with SARS-CoV-2 and its variants, namely, testing the safety of medical diagnostic devices; Technical verification and validation of medical diagnostic tests used in connection with SARS-CoV-2 and its variants; all of the foregoing used in connection with bio specimens from participants of clinical studies; community outreach services, namely, enrolling participants in clinical trials of others, specifically clinical trials relating to medical devices and pharmaceuticals used for treating viruses; community outreach services, namely, enrolling participants in clinical trials of others, specifically clinical trials relating to medical devices and pharmaceuticals used for treating SARS-CoV-2 and its variants